These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11049967)

  • 41. Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a.
    Fukuda T; Chen L; Endo T; Tang L; Lu D; Castro JE; Widhopf GF; Rassenti LZ; Cantwell MJ; Prussak CE; Carson DA; Kipps TJ
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3047-52. PubMed ID: 18287027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy.
    Krackhardt AM; Harig S; Witzens M; Broderick R; Barrett P; Gribben JG
    Blood; 2002 Jul; 100(1):167-73. PubMed ID: 12070023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene transfer of noncleavable cell surface mutants of human CD154 induces the immune response and diminishes systemic inflammatory reactions.
    Masuta Y; Kato K; Tomihara K; Nakamura K; Sasaki K; Takahashi S; Hamada H
    J Immunother; 2007 Oct; 30(7):694-704. PubMed ID: 17893562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
    Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
    Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD40-ligand/interleukin-2 vaccines in chronic lymphocytic leukemia: the impact of vaccine design.
    Rezvani K
    Cytotherapy; 2011 Oct; 13(9):1029-30. PubMed ID: 21916777
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition of T cell/B cell interaction by B-CLL cells.
    Kneitz C; Goller M; Wilhelm M; Mehringer C; Wohlleben G; Schimpl A; Tony HP
    Leukemia; 1999 Jan; 13(1):98-104. PubMed ID: 10049067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunogenetic therapy for B-cell malignancies.
    Kipps TJ; Chu P; Wierda WG
    Semin Oncol; 2000 Dec; 27(6 Suppl 12):104-9. PubMed ID: 11225994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia.
    Ahearne MJ; Willimott S; Piñon L; Kennedy DB; Miall F; Dyer MJ; Wagner SD
    Br J Haematol; 2013 Aug; 162(3):360-70. PubMed ID: 23710828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
    Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
    Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity.
    Schattner EJ; Mascarenhas J; Reyfman I; Koshy M; Woo C; Friedman SM; Crow MK
    Blood; 1998 Apr; 91(8):2689-97. PubMed ID: 9531577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
    Decker T; Schneller F; Sparwasser T; Tretter T; Lipford GB; Wagner H; Peschel C
    Blood; 2000 Feb; 95(3):999-1006. PubMed ID: 10648415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD154-CD40-independent up-regulation of B7-2 on splenic antigen-presenting cells and efficient T cell priming by staphylococcal enterotoxin A.
    Eshima K; Choi Y; Flavell RA
    Int Immunol; 2003 Jul; 15(7):817-26. PubMed ID: 12807820
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD23 is recognized as tumor-associated antigen (TAA) in B-CLL by CD8+ autologous T lymphocytes.
    Bund D; Mayr C; Kofler DM; Hallek M; Wendtner CM
    Exp Hematol; 2007 Jun; 35(6):920-30. PubMed ID: 17533046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenovirus vector infection of chronic lymphocytic leukemia B cells.
    Cantwell MJ; Sharma S; Friedmann T; Kipps TJ
    Blood; 1996 Dec; 88(12):4676-83. PubMed ID: 8977261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
    Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
    Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficient adenovirus-mediated gene transduction of normal and leukemic hematopoietic cells.
    Huang MR; Olsson M; Kallin A; Pettersson U; Tötterman TH
    Gene Ther; 1997 Oct; 4(10):1093-9. PubMed ID: 9415316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes.
    Mayr C; Bund D; Schlee M; Bamberger M; Kofler DM; Hallek M; Wendtner CM
    Exp Hematol; 2006 Jan; 34(1):44-53. PubMed ID: 16413390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
    van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND
    J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells.
    Wallgren A; Festin R; Gidlöf C; Dohlsten M; Kalland T; Tötterman TH
    Blood; 1993 Aug; 82(4):1230-8. PubMed ID: 8102559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies.
    Bohlen H; Hopff T; Manzke O; Engert A; Kube D; Wickramanayake PD; Diehl V; Tesch H
    Blood; 1993 Sep; 82(6):1803-12. PubMed ID: 7691238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.